This article presents many methods for studying the causes of anemia in pregnant women and reviews analyzes based on modern technologies. Data from research literature in Russian was processed and analyzed in electronic search systems cyberleninka.ru, eLIBRARY in international databases Scopus for the period 2017-2024.
Сurrently comorbidity is relevant in the outcome of many diseases. In particular,we are talking about IHD,unstable angina and anemia of varying severity. In 30 patients with coronary artery disease in combination with anemia, 3 valence iron was changed, the drug Sufer (Yuria-Pharm Ukraine) at a dose of 5.0 ml iv for 5 days against the background of standard therapy.In examined patients,that an increase in hemoglobin levels contributes to the normalization of the vibros fraction reduce or disappear angina attacks,increased exercise tolerance
The article describes the pathogenesis of occurring of iron deficiency anemia. The study was conducted in Bukhara. According to him, in each critical period, specific etiological factors predominate, and it is the elimination of these factors in the first place that increases the effectiveness of treatment. The main factors of iron defiency anemia are alimentary insufficiency of in girls of childbearing age is the onset of menstruation, and in women of childbearing age, improper use of intrauterine devices, frequent abortions, metroragias for various reasons, alimentary insufficiency and incomplete acceptance of the previous course of ferrotherapy.
The article presents two cases of hepatitis-associated aplastic anemia in the last year. The literature data on the new nosology are presented. The clinical picture, diagnosis and treatment are discussed. The questions of diagnosis and treatment that affect the prognosis are raised. Treatment preference should be given to allogeneic bone marrow transplantation, as it has better results than aggressive immunosuppressive therapy that is difficult for patients to tolerate.
HCV infection remains one of the leading problems in the diagnosis and treatment of chronic liver disease, given the scale of hepatitis C virus infection worldwide, the significant number of unexamined but at-risk patients, and the incidence of cirrhosis and liver cancer. Anemia is the most common hematological adverse event, which in turn significantly reduces the quality of life of patients during antiviral therapy, their adherence to treatment, and increases the risk of developing cardiovascular, renal and cerebral disorders.
To perform a comparative analysis of anemia of chronic disease (ACD) and iron-deficiency anemia (IDA) in late middle-aged and elderly patients with chronic heart failure (CHF) by ferrokinetic parameters, inflammation indexes, and their associations. Materials and methods. 65 patients with ischemic heart disease were evaluated, including 35 patients with CHF and ACD, 10 patients with CHF and IDA, and 20 patients without CHF, ACD, and IDA (control group, CG). Results. Patients with CHF and IDA had true iron deficiency whereas 54% of patients with CHF and ACD had functional iron deficiency, and 46% of patients had no iron deficiency. Levels of acute phase proteins, ferritin and hepcidin, C-reactive protein (CRP), and interleukin-6 (IL-6) were highly significantly different in patients with CHF and ACD and patients with CHF and IDA; positive and significant correlations were found for levels of IL-6 and ferritin, IL-6 and CRP, and CRP and hepcidin. In patients with CHF and IDA, levels of acute phase proteins, ferritin and hepcidin, CRP, and IL-6 were low and correlations of IL-6 with ferritin, IL-6 with CRP, and CRP with hepcidin were non-significant. Concentrations of erythropoietin were significantly higher in patients with CHF and ACD and patients with CHF and IDA compared to the control group; however, significant differences between them were absent.